HK1149203A1 - Improved radiopharmaceutical composition - Google Patents

Improved radiopharmaceutical composition

Info

Publication number
HK1149203A1
HK1149203A1 HK11103476.4A HK11103476A HK1149203A1 HK 1149203 A1 HK1149203 A1 HK 1149203A1 HK 11103476 A HK11103476 A HK 11103476A HK 1149203 A1 HK1149203 A1 HK 1149203A1
Authority
HK
Hong Kong
Prior art keywords
radiopharmaceutical composition
improved
improved radiopharmaceutical
composition
radiopharmaceutical
Prior art date
Application number
HK11103476.4A
Other languages
English (en)
Inventor
Janne Veggeland
Grethe Karin Madsen
Stig Hemstad
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38670250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1149203(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of HK1149203A1 publication Critical patent/HK1149203A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/025—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11103476.4A 2007-09-21 2011-04-06 Improved radiopharmaceutical composition HK1149203A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97408907P 2007-09-21 2007-09-21
GBGB0718386.6A GB0718386D0 (en) 2007-09-21 2007-09-21 Improved radiopharmaceutical formulation
PCT/EP2008/062528 WO2009037336A2 (fr) 2007-09-21 2008-09-19 Composition radiopharmaceutique améliorée

Publications (1)

Publication Number Publication Date
HK1149203A1 true HK1149203A1 (en) 2011-09-30

Family

ID=38670250

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11103476.4A HK1149203A1 (en) 2007-09-21 2011-04-06 Improved radiopharmaceutical composition

Country Status (8)

Country Link
US (1) US9549999B2 (fr)
EP (1) EP2190484B1 (fr)
JP (1) JP5764328B2 (fr)
CN (1) CN101861170B (fr)
ES (1) ES2562441T3 (fr)
GB (1) GB0718386D0 (fr)
HK (1) HK1149203A1 (fr)
WO (1) WO2009037336A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US7485283B2 (en) * 2004-04-28 2009-02-03 Lantheus Medical Imaging Contrast agents for myocardial perfusion imaging
EP2257315B1 (fr) 2008-02-29 2019-10-23 Lantheus Medical Imaging, Inc. Agents de contraste pour des applications comprenant une imagerie de perfusion
US9687571B2 (en) 2009-04-15 2017-06-27 Lantheus Medical Imaging, Inc. Stabilization of radiopharmaceutical compositions using ascorbic acid
PT2534136T (pt) 2010-02-08 2017-12-15 Lantheus Medical Imaging Inc Métodos para sintetizar agentes de imagiologia, e seus intermediários
CN107362376A (zh) * 2010-07-27 2017-11-21 通用电气健康护理有限公司 放射性药物组合物
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
EP2899195A1 (fr) 2014-01-28 2015-07-29 ROTOP Pharmaka AG Forme stabilisée de tétrofosmine et son utilisation
GB201504064D0 (en) 2015-03-10 2015-04-22 Accretion Biotechnology Ltd Method and kits for preparing radionuclide complexes
CA3075958C (fr) * 2017-11-23 2022-04-19 Jubilant Generics Limited (Formerly A Division Of Jubilant Life Sciences Limited) Composition pharmaceutique comprenant de la tetrofosmine et ses sels pharmaceutiquement acceptables
TW202200214A (zh) * 2020-04-29 2022-01-01 義大利商先進艾斯雷特應用（義大利）公司 放射性標記psma結合配位體的方法及其套組
WO2022167052A1 (fr) * 2021-02-08 2022-08-11 Y-Mabs Therapeutics, Inc. Utilisation d'acide ascorbique comme agent stabilisant pour des anticorps anti-b7-h3
CN114702522A (zh) * 2022-04-12 2022-07-05 无锡市江原实业技贸有限公司 一种双乙氧乙膦烷的制备方法及反应装置

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364920A (en) * 1975-04-30 1982-12-21 Medi-Physics, Inc. Stable diagnostic reagents
US4066183A (en) * 1977-02-24 1978-01-03 L. C. Company, Inc. Chromatographic septum having polyimide coating
JPS60248710A (ja) * 1984-05-22 1985-12-09 Daikin Ind Ltd 新規エチレン／テトラフルオロエチレン系共重合体
JP4269456B2 (ja) * 1999-12-24 2009-05-27 日立電線株式会社 カテーテルチューブの製造方法
EP1347784A2 (fr) * 2000-11-03 2003-10-01 Bristol-Myers Squibb Pharma Company Double imagerie isotopique simultanee d'une perfusion et d'une inflammation cardiaque
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
WO2002067859A2 (fr) * 2001-02-26 2002-09-06 Bristol-Myers Squibb Pharma Company Analogues a l'acide ascorbique pour produits metalloradiopharmaceutiques
GB0223249D0 (en) * 2002-10-08 2002-11-13 Amersham Plc Improved imaging agents
GB0427392D0 (en) 2004-12-15 2005-01-19 Amersham Plc Stabilised 99mTc compositions
AU2007262786B2 (en) 2006-06-21 2012-12-06 Ge Healthcare Limited Radiopharmaceutical products

Also Published As

Publication number Publication date
JP5764328B2 (ja) 2015-08-19
WO2009037336A3 (fr) 2009-09-17
CN101861170B (zh) 2012-09-26
JP2010539222A (ja) 2010-12-16
WO2009037336A2 (fr) 2009-03-26
US20100236958A1 (en) 2010-09-23
GB0718386D0 (en) 2007-10-31
US9549999B2 (en) 2017-01-24
CN101861170A (zh) 2010-10-13
ES2562441T3 (es) 2016-03-04
EP2190484A2 (fr) 2010-06-02
EP2190484B1 (fr) 2015-12-09

Similar Documents

Publication Publication Date Title
GB0718777D0 (en) Composition
GB0700534D0 (en) Composition
GB0717182D0 (en) Composition
HK1149203A1 (en) Improved radiopharmaceutical composition
HUS1500007I1 (hu) Radiogyógyszerészeti kompozíció
GB0722550D0 (en) Composition
GB0714575D0 (en) Composition
GB0710888D0 (en) Composition
GB0715068D0 (en) Improved composition
GB0716591D0 (en) Composition
GB0714569D0 (en) Composition
GB0706343D0 (en) Composition
GB0705885D0 (en) Composition
GB0702446D0 (en) Composition
GB0703719D0 (en) Composition
GB0706739D0 (en) Composition
GB0704651D0 (en) Composition
GB0707972D0 (en) Composition
GB0721430D0 (en) Composition
GB0713976D0 (en) Composition
GB0710559D0 (en) Composition
GB0704659D0 (en) Composition
GB0709282D0 (en) Composition
GB0709708D0 (en) Composition
GB0713298D0 (en) Composition

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210924